Allosteric potentiation by diazoxide of AMPA receptor currents and synaptic potentials

Eur J Pharmacol. 1993 Nov 15;247(3):257-65. doi: 10.1016/0922-4106(93)90193-d.

Abstract

Diazoxide (100-560 microM) reversibly increased the amplitude and duration of excitatory post-synaptic field potentials recorded in the dentate gyrus of hippocampal slices following stimulation of the perforant pathway. In rat cortex mRNA-injected Xenopus oocytes diazoxide (1-1000 microM) alone had little effect on membrane current, but rapidly and reversibly increased (up to 5-fold) current responses to (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA, 30 microM), L-glutamate (100 microM), quisqualate (3 microM), kainate (100 microM) and domoate (3 microM), an effect that was neither mimicked by other activators of ATP-sensitive potassium channels nor blocked by glibenclamide. Diazoxide increased current amplitudes for all concentrations of the 'inactivating' ligands, AMPA, L-glutamate and quisqualate but had little effect on their EC50 values. In contrast, diazoxide increased the apparent potency of the 'non-inactivating' ligands, kainate and domoate, but increased the efficacy of saturating concentrations by only 10-20%. Diazoxide did not modify the competitive inhibition of AMPA and kainate currents by 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX) and thus does not compete for the agonist site as do AMPA and kainate. Similarly, diazoxide neither inhibited the binding of [3H]AMPA or [3H]kainate to rat cortical membranes in competition experiments nor consistently modified the apparent [3H]AMPA affinity (Kd) or receptor density (Bmax) in saturation experiments. These data suggest that diazoxide acts at an allosteric site on the AMPA receptor/channel to potentiate activation in a manner dependent upon the properties of the excitatory agonist.

MeSH terms

  • Allosteric Regulation
  • Animals
  • Diazoxide / pharmacology*
  • Glycine / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / physiology
  • In Vitro Techniques
  • Kinetics
  • Male
  • Membrane Potentials / drug effects
  • N-Methylaspartate / pharmacology
  • Oocytes / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred F344
  • Rats, Wistar
  • Receptors, AMPA / antagonists & inhibitors*
  • Synapses / drug effects*
  • Synapses / physiology
  • Xenopus
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • RNA, Messenger
  • Receptors, AMPA
  • gamma-Aminobutyric Acid
  • N-Methylaspartate
  • Diazoxide
  • Glycine